v3.24.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (4,393,126) $ (5,481,291)
Adjustments to reconcile net loss to net cash provided by operations:    
Stock-based compensation for services and warrant modification 852,305 482,162
Stock-based compensation to employees and directors 402,577 1,534,964
Amortization of debt issuance costs 36,300 36,300
Inducement expense 397,937
Gain on conversion of convertible debt (54,281)
Changes in operating assets and liabilities    
Decrease (Increase) in prepaid expenses and other current assets 70,485 (4,331)
Increase (Decrease) in accounts payable and accrued expenses (142,604) 155,833
Increase (Decrease) accrued payroll and related expenses (79,166) 590,763
Decrease in accrued interest 7,156 27,791
Net cash used in operating activities (2,848,136) (2,712,090)
CASH FLOWS FROM FINANCING ACTIVITIES    
Deferred offering costs 35,000
Proceeds from warrant exercise 1,095,001
Proceeds from exclusivity option sold to Telix 2,000,000
Proceeds from issuance of common stock 914,246 1,402,500
Net cash provided by financing activities 4,009,247 1,437,500
NET INCREASE (DECREASE) IN CASH 1,161,111 (1,274,590)
CASH - Beginning of year 225,276 1,499,866
CASH - End of year 1,386,387 225,276
SUPPLEMENTAL CASH FLOW DISCLOSURES:    
Payment of interest in cash
Payment of income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Accrual of contractual dividends on Series A convertible preferred stock 27,998 27,620
Accrual of contractual dividends on Series B convertible preferred stock 150,895 151,309
Incremental value on Series A modification 282,309
Deemed dividend on warrant modifications 41,225
Deemed dividend on Series A conversion price modifications 96,245 342,497
Deemed dividend on Series B conversion price modifications 209,296 30,938
Conversion of debentures and accrued expenses to common stock 35,000
Conversion of accrued salary and bonus to common stock 606,981
Conversion of convertible debt and accrued interest to common stock 519,712 132,934
Conversion of Series A preferred stock to common stock 240,000
Deferred Compensation for employees and consultants 1,424,384
Subscription receivable for proceeds from sale of common stock $ 250,000